Once they enter the body, drugs, apart from carrying out their therapeutic function, are biochemically transformed by the action of the metabolic machinery, a process that facilitates their expulsion. This biotransformation ...
Feb 9, 2024
0
51
A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates, a new in-vitro study finds. Researchers from Charles Darwin University (CDU) and RMIT investigated programmed ...
Feb 8, 2024
0
17
Every week, more than 400 men are diagnosed with prostate cancer. With treatment, survival rates for prostate cancer are high, but understanding the treatment options and side effects can be confusing.
Feb 5, 2024
0
0
The rate of venous thromboembolism is increased in association with cancer surgery, according to a study published online Feb. 2 in JAMA Network Open.
Feb 2, 2024
0
2
It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells. A recent study published in Communications Biology by the ...
Feb 2, 2024
0
8
Cancer is one of the leading causes of death in the United States, and for Black and African Americans, the numbers are even worse. The U.S. Department of Health and Human Services (HHS) Office of Minority Health found Black/African ...
Feb 1, 2024
0
0
An increase in annual cardiorespiratory fitness by 3% or more is linked to a 35% lower risk of developing, although not dying from, prostate cancer, suggests research published online in the British Journal of Sports Medicine.
Jan 30, 2024
0
1
Pfizer reported a quarterly loss Tuesday on much lower sales of COVID-19 products as it emphasized progress on cost-cutting and drug development initiatives.
Jan 30, 2024
0
1
Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, especially those with ...
Jan 26, 2024
0
1
A lack of cancer progression could be used as a substitute for overall survival in metastatic hormone-sensitive prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology, ...
Jan 26, 2024
0
0
